Rebecca B. Perkins, MD, MSc
Associate Professor
Boston University School of Medicine
Dept of Obstetrics & Gynecology

MD, Harvard Medical School
MSc, Boston University School of Public Health

My area of research is cervical cancer prevention in underserved women. My current work focuses on HPV vaccination in females and males, as well as the impact of new screening guidelines on cervical dysplasia/cancer outcomes.

Boston University
BU-BMC Cancer Center

2011 BMC: American College of Obstetrics and Gynecology-Merck Adolescent Health Research Award
2007 BMC: American College of Obstetrics and Gynecology-Merck Adolescent Health Research Award

Cervical Cancer: PROGRESS for Prevention
07/01/2019 - 06/30/2023 (PI)
Moffitt Cancer Center American Cancer Soc

Understanding the impact of COVID-19 on cervical cancer screening and management of abnormal results in underserved women
02/01/2021 - 01/31/2022 (PI)
American Cancer Society

IPA: Cervical Cancer Moonshot
11/04/2019 - 11/04/2021 (PI)
National Cancer Institute/NIH/DHHS National Cancer Inst

Improving Provider HPV Vaccine Conversations Through Education and Training
01/01/2016 - 12/31/2019 (PI)
American Cancer Soc

Improving Immunization Rates and Enhancing Prevention Through Partnerships with Providers
09/30/2014 - 09/30/2019 (PI)
American Academy of Pediatrics CDC

Provider Education to improve HPV Vaccine Use
07/01/2009 - 06/30/2015 (PI)
American Cancer Soc

Clarifying the effects of race and socioeconomic status on disparities in HPV vaccination rates
09/01/2012 - 08/31/2014 (PI)
1U01 IP000636-01


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Fuss TL, Devera JL, Pierre-Joseph N, Perkins RB. Attitudes and Communication Preferences for Vaccines among Pregnant Women Receiving Care at a Safety-net Hospital. Womens Health Issues. 2021 Oct 08. PMID: 34635378
  2. Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, Huh WK, Kim JJ, Moscicki AB, Nayar R, Saraiya M, Sawaya GF, Wentzensen N, Schiffman M. Erratum: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis. 2021 10 01; 25(4):330-331. PMID: 34542089
  3. Munshi VN, Perkins RB, Sy S, Kim JJ. Cost-effectiveness Analysis of the 2019 ASCCP Risk-Based Management Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors. Am J Obstet Gynecol. 2021 Sep 18. PMID: 34547295
  4. Perkins RB, Adcock R, Benard V, Cuzick J, Waxman A, Howe J, Melkonian S, Gonzales J, Wiggins C, Wheeler CM. Clinical follow-up practices after cervical cancer screening by co-testing: A population-based study of adherence to U.S. guideline recommendations. Prev Med. 2021 Aug 18; 153:106770. PMID: 34416221
  5. Fowler ML, Wang D, Chia V, Handal-Orefice R, Latortue-Albino P, Mulekar S, White K, Perkins R. Management of Cervical Ectopic Pregnancies: A Scoping Review. Obstet Gynecol. 2021 07 01; 138(1):33-41. PMID: 34259461
  6. Drainoni ML, Biancarelli D, Jansen E, Bernstein J, Joseph N, Eun TJ, Fenton AHTR, Clark JA, Hanchate A, Legler A, Schuch TJ, Leschly K, Perkins RB. Provider and Practice Experience Integrating the Dose-HPV Intervention into Clinical Practice. J Contin Educ Health Prof. 2021 07 01; 41(3):195-201.View Related Profiles. PMID: 33973928
  7. Wentzensen N, Clarke MA, Perkins RB. Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparities. Prev Med. 2021 10; 151:106596. PMID: 34217415; PMCID: PMC8241689; DOI: 10.1016/j.ypmed.2021.106596;
  8. Fisher-Borne M, Isher-Witt J, Comstock S, Perkins RB. Understanding COVID-19 impact on cervical, breast, and colorectal cancer screening among federally qualified healthcare centers participating in "Back on track with screening" quality improvement projects. Prev Med. 2021 10; 151:106681. PMID: 34217422; PMCID: PMC8241686; DOI: 10.1016/j.ypmed.2021.106681;
  9. Mills JM, Morgan JR, Dhaliwal A, Perkins RB. Eligibility for cervical cancer screening exit: Comparison of a national and safety net cohort. Gynecol Oncol. 2021 Aug; 162(2):308-314.View Related Profiles. PMID: 34090706
  10. Perkins RB, Foley S, Hassan A, Jansen E, Preiss S, Isher-Witt J, Fisher-Borne M. Impact of a Multilevel Quality Improvement Intervention Using National Partnerships on Human Papillomavirus Vaccination Rates. Acad Pediatr. 2021 Sep-Oct; 21(7):1134-1141. PMID: 34023489
Showing 10 of 113 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 113 publications over 17 distinct years, with a maximum of 20 publications in 2020


Inadequate Cervical Cancer Screening Puts Women 65 and Older at Risk

HealthCity 6/17/2021

Most Older Women Do Not Meet Criteria to Stop Cervical Cancer Screening

MedPage Today 6/10/2021

Study Shows Inadequate Screening for Older Women May Contribute to High Cancer Rates and Mortality

Onco'Zine 6/8/2021

Two Thirds of Women Do Not Meet Cervical Cancer Screening Exit Criteria

Obstetrics & Gynecology Consultant 6/3/2021

ASCCP guidelines prioritize risk for management of abnormal screenings

Contemporary OB/GYN 5/1/2021

COVID-19 Vaccine Two-Dose Completion Is Crucial for Public Health

HealthCity 3/18/2021

Provider Language Choice Associated with Higher Vaccination Rates

HealthCity 1/14/2021

Study: Higher Vaccine Rates Associated with Indicative Language by Provider, More Efficient

Pharmacy Times 1/14/2021

Clear Prompts Can Improve Vaccination Rates, Patient Satisfaction

Patient Engagement HIT 1/14/2021

How To Make Sure People Come Back For Their Second COVID-19 Vaccine Dose

FiveThirtyEight 12/10/2020

New ASCCP consensus guidelines for managing abnormal cervical cancer screening test results

Contemporary OB/GYN 10/26/2020

New Guidance for Testing of Minimal Abnormalities Detected in Cervical Cancer Screening

Cancer Network 10/18/2020

ASCCP issues new guidelines for managing abnormal results on cervical cancer screening

News Medical 6/26/2020

Multilevel Interventions May Boost HPV Vaccination Rates

Oncology Nurse Advisor 6/24/2020

Research Finds Multilevel Interventions Improve HPV Vaccination Rates of Series Initiation, Completionation, Completion

Pharmacy Times 6/19/2020

How To Improve HPV Vaccination Rates For Everyone

Precision Vaccinations: 6/17/2020

Letters: Faulting the U.S. Response to the Coronavirus

The New York Times 3/3/2020

The ABCs of HPV

Elemental 7/23/2019

Is Power Morcellation a Bigger Problem Than We Thought?

Outpatient Surgery 11/30/2015
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

HPV vaccination/ cervical cancer screening/ health disparities
Contact for Mentoring:

85 E. Concord St
Boston MA 02118
Google Map

Perkins's Networks
Click the "See All" links for more information and interactive visualizations
Media Mentions
Similar People
Same Department